SUBSCRIBE
SUBSCRIBE

Marea Therapeutics

NEWS
NextGen
BioSpace’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
January 7, 2025
 · 
5 min read
 · 
Heather McKenzie
IN THE PRESS
Press Releases
Marea Therapeutics Appoints Charmi Turner as Senior Vice President, People & Culture
May 20, 2025
 · 
2 min read
Press Releases
Marea Therapeutics Announces Publication in The Lancet of Positive Data from Phase 2a Clinical Trial of MAR001 for Cardiovascular Disease
May 16, 2025
 · 
3 min read
Press Releases
Marea Therapeutics Presents Positive Data from Phase 2a Clinical Trial of MAR001, Being Developed for Cardiovascular Disease, in Late-Breaking Oral Session at the 93rd EAS Congress
May 7, 2025
 · 
5 min read
Press Releases
Marea Therapeutics Announces Late-Breaking Oral Presentation at the 93rd EAS Congress
April 15, 2025
 · 
1 min read
Press Releases
Marea Therapeutics Forms Clinical Scientific Advisory Board
January 21, 2025
 · 
5 min read
Press Releases
Marea Therapeutics Provides Update on Corporate Progress Including Positive Topline Results from Phase 2a Clinical Trial of MAR001 for Cardiovascular Disease and Disclosure of Second Lead Pipeline Program for the Treatment of Acromegaly
January 9, 2025
 · 
4 min read
Press Releases
Marea Therapeutics Expands Management Team and Board of Directors
December 20, 2024
 · 
3 min read
Biotech Bay
Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases
June 18, 2024
 · 
6 min read
JOBS